Charles River’s $1B revenue; Theratechnologies restarts HIV drug supply
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. Charles River Laboratories’ stock {$CRL} was up 7% on Wednesday after beating Wall Street estimates for ...
